metastatic/adv melanoma (mML) | |||
mML - L1 - all population | mML - L1 - BRAF mutant | mML - L1 - BRAF wild | |
anti-PD-(L)1 | |||
atezolizumab based treatment | |||
atezolizumab plus cometinib | IMspire-170 | ||
atezolizumab plus SoC | IMspire-150 ... | ||
nivolumab based treatment | |||
nivolumab alone | CheckMate 067 ... | CheckMate 066 | |
nivolumab followed by ipilimumab |